Pine Bark Extract (Pycnogenol) for Antioxidant Support

Research suggests that Pycnogenol (pine bark extract) possesses meaningful antioxidant activity, with laboratory and mechanistic studies consistently demonstrating its ability to scavenge free radicals, regenerate antioxidants such as vitamin C and glutathione, and produce active metabolites — particularly one called M1 — that may themselves drive anti-inflammatory and tissue-protective effects. Several supporting reviews and a 2025 randomized controlled trial found measurable reductions in inflammatory markers under controlled conditions, and earlier clinical trials reported modest benefits for blood pressure, joint symptoms, and venous health, suggesting the antioxidant activity may translate into real physiological effects. However, two systematic reviews and a Cochrane-style meta-analysis — collectively covering 27 trials and over 1,600 participants across multiple conditions — rated the overall clinical evidence as very low certainty, citing trials that were small, methodologically inconsistent, and too limited in number to support firm conclusions for any specific health application. The body of evidence, while mechanistically plausible and directionally encouraging, remains insufficient to establish definitive clinical benefit, and researchers across multiple reviews have called for larger, more rigorously designed trials before stronger conclusions can be drawn.